Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Can VEGF-D and VEGFR-3 be used as biomarkers for therapeutic decisions in patients with gastric cancer?

Nature Clinical Practice Oncology volume 3, pages 418–419 (2006)Cite this article

boxed-textJüttner et al. (2006) Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma. J Clin Oncol 24: 228–240

Internal and external multicenter validation, and randomized phase III trials, are required before the VEGF system can be translated as a biomarker classifier into gastric cancer treatment practice

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Roukos DH and Kappas AM (2005) Perspectives in the treatment of gastric cancer. Nat Clin Pract Oncol 2: 98–107

    Article  Google Scholar 

  2. Simon R (2005) Roadmap for developing and validating therapeutically relevant genomic classifiers. J Clin Oncol 23: 7332–7341

    Article  CAS  Google Scholar 

  3. Ransohoff DF (2005) Bias as a threat to the validity of cancer molecular-marker research. Nat Rev Cancer 5: 142–149

    Article  CAS  Google Scholar 

  4. Kattan MW et al. (2005) Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol 21: 3647–3650

    Article  Google Scholar 

  5. Chen CN et al. (2005) Gene expression profile predicts patient survival of gastric cancer after surgical resection. J Clin Oncol 23: 7286–7295

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. assistant professor and Director of the Surgical Oncology and Genomics Research Unit,

    Dimitrios H Roukos, Theodore Liakakos, Gabriel Karatzas & Angelos M Kappas

  2. professor and Head of Department at the Department of Surgery, Ioannina University School of Medicine, Greece

    Dimitrios H Roukos, Theodore Liakakos, Gabriel Karatzas & Angelos M Kappas

  3. professor of Surgery,

    Dimitrios H Roukos, Theodore Liakakos, Gabriel Karatzas & Angelos M Kappas

  4. professor and Head of the Department of Surgery, at the Attiko University Hospital, University of Athens, Greece

    Dimitrios H Roukos, Theodore Liakakos, Gabriel Karatzas & Angelos M Kappas

Authors
  1. Dimitrios H Roukos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Theodore Liakakos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gabriel Karatzas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Angelos M Kappas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dimitrios H Roukos.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roukos, D., Liakakos, T., Karatzas, G. et al. Can VEGF-D and VEGFR-3 be used as biomarkers for therapeutic decisions in patients with gastric cancer?. Nat Rev Clin Oncol 3, 418–419 (2006). https://doi.org/10.1038/ncponc0540

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0540

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing